HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

1:58:18 Jan 14, 2026
About this episode
Prof Giuseppe Curigliano from the University of Milan in Italy, Prof Nadia Harbeck from LMU University Hospital in Munich, Germany, Dr Ian E Krop from Yale Cancer Center, Dr Nancy U Lin from Dana-Farber Cancer Institute and Dr Joyce O’Shaughnessy from Baylor University Medical Center discuss real-world cases and recent clinical data pertinent to the management of HER2-positive breast cancer. CME information and select publications here.
Select an episode
0:00 0:00